Academic Journal
Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool
| العنوان: | Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool |
|---|---|
| المؤلفون: | Figueroa-Campos, Andrés, Sánchez-Dengra, Bárbara, Merino, Virginia, Dahan, Arik, Gonzalez-Alvarez, Isabel, García-Arieta, Alfredo, Gonzalez-Alvarez, Marta, Bermejo, Marival |
| المساهمون: | European Regional Development Fund, Ministerio de Ciencia, Innovación y Universidades, Ministerio de Economía, Industria y Competitividad |
| بيانات النشر: | MDPI AG |
| سنة النشر: | 2020 |
| المجموعة: | Universitat Politécnica de Valencia: RiuNet / Politechnical University of Valencia |
| مصطلحات موضوعية: | Candesartan cilexetil, IVIVC, Bioequivalence, BCS, Predictive in vivo-dissolution |
| الوصف: | [EN] The main objective of this investigation was to develop an in vitro-in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studies. Data from two bioequivalence studies were scaled and combined to obtain the dataset for the IVIVC. Two-step and one-step approaches were used to develop the IVIVC. Experimental solubility and permeability data confirmed candesartan cilexetil. Biopharmaceutic Classification System (BCS) class II candesartan average plasma profiles were deconvoluted by the Loo-Riegelman method to obtain the oral fractions absorbed. Fractions dissolved were obtained in several conditions in USP II and IV apparatus and the results were compared calculating the f(2)similarity factor. Levy plot was constructed to estimate the time scaling factor and to make both processes, dissolution and absorption, superimposable. The in vitro dissolution experiment that reflected more accurately the in vivo behavior of the products of candesartan cilexetil employed the USP IV apparatus and a three-step pH buffer change, from 1.2 to 4.5 and 6.8, with 0.2% of Tween 20. This new model was able to predict the in vivo differences in dissolution and it could be used as a risk-analysis tool for formulation selection in future bioequivalence trials. ; This research was funded by the Agencia Estatal de Investigacion and the European Union, through FEDER (Fondo Europeo de Desarrollo Regional), grant number SAF2016-78756 (AEI/FEDER, EU). Barbara Sanchez-Dengra received a grant from the Ministry of Science, Innovation and Universities of Spain, grant number FPU17/00530. ; Figueroa-Campos, A.; Sánchez-Dengra, B.; Merino, V.; Dahan, A.; Gonzalez-Alvarez, I.; García-Arieta, A.; Gonzalez-Alvarez, M. (2020). Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool. Pharmaceutics. 12(7):1-21. ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1999-4923 |
| Relation: | Pharmaceutics; info:eu-repo/grantAgreement/MCIU//FPU17%2F00530/; info:eu-repo/grantAgreement/MINECO//SAF2016-78756/; https://doi.org/10.3390/pharmaceutics12070633; http://hdl.handle.net/10251/192980; urn:eissn:1999-4923; PMC7408357 |
| DOI: | 10.3390/pharmaceutics12070633 |
| الاتاحة: | http://hdl.handle.net/10251/192980 https://doi.org/10.3390/pharmaceutics12070633 |
| Rights: | http://creativecommons.org/licenses/by/4.0/ ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.C27AF3F3 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics12070633 |